Author Question: When the estrogen in hormone replacement therapy (HRT) was linked to uterine cancer in the 1970s, ... (Read 86 times)

crobinson2013

  • Hero Member
  • *****
  • Posts: 535
When the estrogen in hormone replacement therapy (HRT) was linked to uterine cancer in the 1970s, the pharmaceutical industry responded by
 
  A) changing the product to include the hormone progestin.
  B) contending that the benefits outweighed the risks.
  C) conducting their own studies to show that estrogen was harmless.
  D) discontinuing to market the HRT medications.

Question 2

Janet just experienced menopause. Consequently, which of the following could she expect?
 
  A) A decrease of LDL
  B) An increase in HDL
  C) Lower blood pressure
  D) An increase in the rate of bone loss



brittanywood

  • Sr. Member
  • ****
  • Posts: 355
Answer to Question 1

A

Answer to Question 2

D



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

According to the Migraine Research Foundation, migraines are the third most prevalent illness in the world. Women are most affected (18%), followed by children of both sexes (10%), and men (6%).

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

Did you know?

More than 2,500 barbiturates have been synthesized. At the height of their popularity, about 50 were marketed for human use.

Did you know?

Once thought to have neurofibromatosis, Joseph Merrick (also known as "the elephant man") is now, in retrospect, thought by clinical experts to have had Proteus syndrome. This endocrine disease causes continued and abnormal growth of the bones, muscles, skin, and so on and can become completely debilitating with severe deformities occurring anywhere on the body.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library